These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10027499)

  • 21. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.
    Shaddy RE; Curtin EL; Sower B; Tani LY; Burr J; LaSalle B; Boucek MM; Mahony L; Hsu DT; Pahl E; Burch GH; Schlencker-Herceg R
    Am Heart J; 2002 Sep; 144(3):383-9. PubMed ID: 12228773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 24. CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.
    Coats AJ
    Int J Cardiol; 2001 Apr; 78(2):109-13. PubMed ID: 11334653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin-induced cardiomyopathy treated with carvedilol.
    Fazio S; Palmieri EA; Ferravante B; Bonè F; Biondi B; Saccà L
    Clin Cardiol; 1998 Oct; 21(10):777-9. PubMed ID: 9789703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carvedilol and heart failure: new findings].
    Cosín Aguilar J
    Rev Esp Cardiol; 1996 Feb; 49(2):85-7. PubMed ID: 8948716
    [No Abstract]   [Full Text] [Related]  

  • 28. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.
    Fleming T; Borer J; Armstrong PW; Pfeffer M;
    Circulation; 2003 Jan; 107(2):e9002-3. PubMed ID: 12538443
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Hjalmarson A; Waagstein F
    Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
    [No Abstract]   [Full Text] [Related]  

  • 31. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
    J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure].
    Zaikin SY; Iosava IK; Vasechkin SS; Gruzdev AK; Sidorenko BA
    Kardiologiia; 2002; 42(4):33-6. PubMed ID: 12494164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
    Doggrell SA
    Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effectiveness of carvedilol in heart failure].
    Kárpáti K; Brodszky V; Farsang C; Jermendy G; Vándorfi G; Zámolyi K; Gulácsi L
    Orv Hetil; 2006 Oct; 147(40):1931-7. PubMed ID: 17111685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb; 145(8):57. PubMed ID: 12661451
    [No Abstract]   [Full Text] [Related]  

  • 39. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
    Di Lenarda A; Sabbadini G; Sinagra G
    Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
    [No Abstract]   [Full Text] [Related]  

  • 40. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.
    Remme WJ;
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):69-77. PubMed ID: 11504166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.